4.6 Article

Economic Evaluation of Extended Early Intervention Service vs Regular Care Following 2 Years of Early Intervention: Secondary Analysis of a Randomized Controlled Trial

期刊

SCHIZOPHRENIA BULLETIN
卷 47, 期 2, 页码 465-473

出版社

OXFORD UNIV PRESS
DOI: 10.1093/schbul/sbaa130

关键词

first-episode psychosis; cost-effectiveness analysis; duration of untreated psychosis; randomized controlled trial

资金

  1. Canadian Institutes of Health Research [MCT 94189]
  2. Canada Research Chairs program
  3. Fonds de recherche du Quebec - Sante
  4. Canadian Institutes of Health Research

向作者/读者索取更多资源

Cost-effectiveness study found that extending early intervention services (EIS) for psychosis may be more cost-effective for patients with a duration of untreated psychosis (DUP) of 12 weeks or less.
Cost-effectiveness studies of early intervention services (EIS) for psychosis have not included extension beyond the first 2 years. We sought to evaluate the cost-effectiveness of a 3-year extension of EIS compared to regular care (RC) from the public health care payer's perspective. Following 2 years of EIS in a university setting in Montreal, Canada, patients were randomized to a 3-year extension of EIS (n = 110) or RC (n = 110). Months of total symptom remission served as the main outcome measure. Resource use and cost data for publicly covered health care services were derived mostly from administrative systems. The incremental cost-effectiveness ratio (ICER) and cost-effectiveness acceptability curve were produced. Relative cost-effectiveness was estimated for those with duration of untreated psychosis (DUP) of 12 weeks or less vs longer. Extended early intervention had higher costs for psychiatrist and nonphysician interventions, but total costs were not significantly different. The ICER was $1627 per month in total remission. For the intervention to have an 80% chance of being cost-effective, the decision-maker needs to be willing to pay $5942 per month of total symptom remission. DUP <= 12 weeks was associated with a reduction in costs of $12 276 even if no value is placed on additional months in total remission. Extending EIS for psychosis for people, such as those included in this study, may be cost-effective if the decision-maker is willing to pay a high price for additional months of total symptom remission, though one commensurate with currently funded interventions. Cost-effectiveness was much greater for people with DUP <= 12 weeks.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据